Latest news with #CMRSurgical
Yahoo
10-04-2025
- Business
- Yahoo
SoftBank Bets $200M On CMR Surgical, The UK Startup Taking On $178B Intuitive With Robots That Have Performed 30,000 Surgeries
In the world of medical tech-dominated by giants, one UK-based startup is going for the jugular. CMR Surgical just got itself more than $200 million in new capital to pump the pedal down on a global rollout of its surgical robotics system and, even more daring, to make a serious dent in the U.S. market, where $180 billion kingpin Intuitive Surgical reigns. With heavyweight backers like SoftBank, LightRock, Ally-Bridge, and a $68 million chunk of debt funding from Trinity Capital, the round signals deep-pocketed belief in CMR Surgical's trajectory. According to Sifted, this new cash pile brings the company's total raised to north of $1 billion, putting it squarely in unicorn territory, with a $3 billion valuation to match. Don't Miss: Deloitte's fastest-growing software company partners with Amazon, Walmart & Target – CMR Surgical is not exactly playing small ball. It's the best-capitalized surgical robots startup on earth, according to Dealroom. Since beginning its operations in 2014, it has raised more than most startups dream of raising. Its last large haul was a $600 million Series D round in 2021, which increased the startup's valuation tremendously. In 2023, the company also secured a $170 million convertible loan note. Patrick Vallance, UK science minister, said in a statement released by the company, 'This successful funding round of more than $200 million is a clear vote of confidence in the company, the potential of surgical robotics, and in the UK's life science ecosystem, which continues to produce innovative companies at an impressive rate.' Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — . The centerpiece of CMR Surgical's aspiration is Versius, a robotic surgery platform for trials in colorectal, gynecology, thoracic, urology, and general soft tissue procedures. It has already begun making an impact where used, with over 30,000 procedures carried on around the world. Versius helps with instruments like endoscopes, forceps, and scissors, but it also records and feeds back surgical data to staff in real time, converting the operating room into something resembling a high-precision data level of integration is a big part of why the robot is now the world's second most-adopted soft tissue surgical robot, second only to Intuitive Surgical's long-established Surgical knows that it faces a turning point. 'We are now at a pivotal stage, poised to capitalize on significant opportunities for market expansion, including in the U.S. while continuing to penetrate deeper into existing markets,' CEO Massimiliano Colella said. Now that the company has a new war chest, it is preparing for a real push. Although it's topping the funding charts in Europe, it's not alone in the wider race to use robotic surgery. DistalMotion, based in Switzerland raised $150 million in 2023. The same year, Moon Surgical from France raised $55 million, and in 2024, Italy's Medical Microinstruments picked up $110 million. CMR Surgical's entry into the U.S. indicates an intent to disrupt the status quo. The competition in surgical robotics is entering a new, more decisive phase, with $200 million in new funding to enable its next stage of growth. Read Next:'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article SoftBank Bets $200M On CMR Surgical, The UK Startup Taking On $178B Intuitive With Robots That Have Performed 30,000 Surgeries originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
04-04-2025
- Business
- Yahoo
CMR secures over $200m to commercialise surgical robotic system
CMR Surgical has completed a financing round of more than $200m, combining equity and debt capital to expedite the commercialisation of its Versius Surgical Robotic System, particularly focusing on the US market. Through these funds, the company also aims to bolster its growth strategy. The financing round is supported by all current investors and includes a debt investment from alternative asset manager Trinity Capital, which has pledged up to $68.75m in growth capital to the company as part of this current financing initiative. The funds will also support ongoing innovation and product development, including the introduction of the enhanced Versius Plus. Armentum Partners served as the company's financial adviser for the debt financing of the funding round. Deployed in more than 30,000 surgeries across over 30 nations so far, the Versius system aims to enhance surgical procedures. It received de novo marketing clearance from the US Food and Drug Administration (FDA) last year for cholecystectomy procedures in adults aged over 22. Versius 'biomimics' the arm of the human, offering surgeons dexterity and precision with fully wristed, small instruments. CMR is anticipating the broadening of its clinical footprint through two ongoing trials, a multi-centre prospective study of Versius in paediatric surgery and a transoral robotic surgery (TORS) study, showcasing the system's 'versatility' in surgical applications. CMR Surgical CEO Massimiliano Colella said: 'We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion, including in the US, while continuing to penetrate deeper into existing markets. 'I would like to give thanks to our chief financial officer, Andre Nel, and the team for securing this financing to provide the foundation for realising our strategic vision of making robotic-assisted surgery accessible to all patients who need it whilst accelerating future product development.' With its headquarters in the UK, CMR is collaborating with surgeons and hospitals to make robotic minimal-access surgery widely 'affordable' and 'accessible'. "CMR secures over $200m to commercialise surgical robotic system" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
03-04-2025
- Business
- Yahoo
CMR Surgical secures $200M for US robot rollout
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. CMR Surgical said Wednesday it closed a financing round worth more than $200 million to support commercializing the robot maker's Versius soft tissue system. The Cambridge, U.K.-based company now has its sights on the U.S. market, after winning Food and Drug Administration de novo authorization for the robot in October with an initial indication for gallbladder removal surgery. CMR plans to use the new funds to expand its worldwide rollout of Versius to hospitals, with a 'major focus' in the U.S., and to advance innovation and product development in surgical robotics. CMR, one of multiple companies competing for a portion of the growing market in robotically assisted surgery, claims that Versius is the second most utilized soft tissue robot worldwide, after industry leader Intuitive Surgical's da Vinci system. Mark Slack, CMR co-founder and chief medical officer, told MedTech Dive last year that new competition will be healthy for the market. The company built its base in global markets before preparing to compete with Intuitive on its home turf in the U.S., Slack said. CEO Massimiliano Colella, in a statement Wednesday, said CMR is focused on further penetration of existing markets in addition to the U.S. launch. 'We are now at a pivotal stage, poised to capitalise on significant opportunities for market expansion,' Colella said. Versius has been used to complete more than 30,000 surgical cases globally in more than 30 countries, across specialities including colorectal, general, gynecology, thoracic and urology surgeries. The company is also studying use of the robot in pediatric surgery and other applications. The funding round combines equity and debt capital and is backed by new investor Trinity Capital and existing CMR investors, the company said. Recommended Reading 4 robotic surgery trends to watch in 2025
Yahoo
21-02-2025
- Health
- Yahoo
Parents 'amazed' as surgical robots treat baby boy
Parents of a four-month-old baby boy who was the youngest in the world to have robot-assisted surgery have said they were "amazed" at the result after fearing treatment was not possible. Mohammed went under the knife at Royal Manchester Children's Hospital for a kidney issue as part of a clinical trial using surgical robots designed to mimic human joints. His mother Mariam said she was concerned he would be too small for surgery, but the "revolutionary care" had made a successful operation possible. David Keene, a consultant surgeon at the hospital, said medics were excited by he "level of precision" the robot technology had brought. Mohammed was treated under a trial of the use of the Versius Surgical System in paediatric surgery. The technology by British Medical firm CMR Surgical consists of small, portable surgical robots with modular arms that can be controlled by surgeons. It allows for more precise movements and for faster recovery time by making operations less invasive. In baby Mohammed's case, he underwent surgery on a tube that connects his bladder to his kidneys, which were at risk of severe infection. "We didn't think it would be possible for him to have the surgery needed to fix the problem at just four months old," Mariam said. She said: "It was a huge relief when we found out that he wouldn't have to wait because doctors can operate so precisely using the robotic system. "Mohammed was back home just three days after the surgery and he's doing great." The technology has allowed surgeons at the hospital, which is part of part of Manchester University NHS Foundation Trust, to do two operations a day, where previously only one surgery would be carried out. Mr Keene said this new generation of surgical robots was "particularly suited" to reconstructive surgeries involving children. About 25 robotic urology operations have been carried out at the hospital since August 2024 as part of the study. Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram and watch BBC North West Tonight on BBC iPlayer Hospital carries out 100th robotic spinal surgery Manchester University NHS Foundation Trust
BBC News
21-02-2025
- Health
- BBC News
Parents 'amazed' as surgical robots make baby boy's treatment possible
Parents of a four-month-old baby boy who was the youngest in the world to have robot-assisted surgery have said they were "amazed" at the result after fearing treatment was not possible. Mohammed went under the knife at Royal Manchester Children's Hospital for a kidney issue as part of a clinical trial using surgical robots designed to mimic human mother Mariam said she was concerned he would be too small for surgery, but the "revolutionary care" had made a successful operation possible. David Keene, a consultant surgeon at the hospital, said medics were excited by he "level of precision" the robot technology had brought. Mohammed was treated under a trial of the use of the Versius Surgical System in paediatric technology by British Medical firm CMR Surgical consists of small, portable surgical robots with modular arms that can be controlled by allows for more precise movements and for faster recovery time by making operations less invasive. 'Huge relief' In baby Mohammed's case, he underwent surgery on a tube that connects his bladder to his kidneys, which were at risk of severe infection. "We didn't think it would be possible for him to have the surgery needed to fix the problem at just four months old," Mariam said. She said: "It was a huge relief when we found out that he wouldn't have to wait because doctors can operate so precisely using the robotic system."Mohammed was back home just three days after the surgery and he's doing great."The technology has allowed surgeons at the hospital, which is part of part of Manchester University NHS Foundation Trust, to do two operations a day, where previously only one surgery would be carried out. Mr Keene said this new generation of surgical robots was "particularly suited" to reconstructive surgeries involving children. About 25 robotic urology operations have been carried out at the hospital since August 2024 as part of the study. Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram and watch BBC North West Tonight on BBC iPlayer
